For research use only. Not for therapeutic Use.
YU253434(Cat No.:I038618)is an experimental small molecule compound being studied for its potential therapeutic applications, particularly in the area of cancer treatment. It functions by targeting specific molecular pathways that regulate tumor growth, survival, and metastasis. Preclinical studies suggest that YU253434 may inhibit key enzymes or receptors involved in cancer cell proliferation, offering a potential treatment for various cancer types. Research is focused on evaluating its pharmacological properties, including its safety, efficacy, and bioavailability.
Catalog Number | I038618 |
CAS Number | 2408801-88-5 |
Synonyms | YU253434; YU-253434; YU 253434; |
Molecular Formula | C27H26N8O12S |
Purity | 98% |
Solubility | Soluble in DMSO |
Appearance | Solid powder |
Storage | Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years). |
IUPAC Name | (S,Z)-6-(2-(2-aminothiazol-4-yl)-2-(((2-carboxypropan-2-yl)oxy)imino)acetamido)-2-((2-(5,6-dihydroxy-1,3-dioxoisoindolin-2-yl)ethyl)carbamoyl)-5-oxo-6,7-dihydro-1H,5H-pyrazolo[1,2-a]pyrazole-3-carboxylic acid |
InChI | InChI=1S/C27H26N8O12S/c1-27(2,25(45)46)47-32-17(14-9-48-26(28)31-14)20(39)30-13-8-33-7-12(18(24(43)44)35(33)23(13)42)19(38)29-3-4-34-21(40)10-5-15(36)16(37)6-11(10)22(34)41/h5-6,9,13,36-37H,3-4,7-8H2,1-2H3,(H2,28,31)(H,29,38)(H,30,39)(H,43,44)(H,45,46)/b32-17-/t13-/m0/s1 |
InChIKey | NDBWOXXNCCSABA-JFLUISNFSA-N |
SMILES | O=C(NCCN1C(C(C=C(O)C(O)=C2)=C2C1=O)=O)C3=C(C(O)=O)N4N(C[C@H](NC(/C(C5=CSC(N)=N5)=NOC(C)(C(O)=O)C)=O)C4=O)C3 |